10 Stars all around
Oliver Sum-Ping, MD, a Clinical Associate Professor of Psychiatry and Sleep Medicine at Stanford Medicine who wasnt affiliated with the research told Healthline, The results suggest substantial potential for the role of these medications for at least mitigating OSA. The SURMOUNT-OSA trial was a multi-center, randomized, double-blind, placebo-controlled trial conducted with 469 patients, all of whom had OSA
By supplementing with a bioavailable form, you are essentially giving your liver the "backup" it needs to do its job effectively
Complexity increases with additional stack components, requiring careful attention to interactions, timing, and individual response assessment
Gopal Grandhige, MD, FACS, Board-Certified Surgeon Last Reviewed: June 27, 2026 Epithalon peptide is used mainly as an experimental longevity tool
Monitor how well improvements hold after discontinuing active treatment